Real-world survival of relapsed compared to de-novo stage IV diagnosis of advanced non-small cell lung cancer Published September 2019 Citation Kerrigan, KC, Halland, B, Adamson, BJS, Patel, SB, Akerley, WL. . World Conference on Lung Cancer. . https://wclc2019.iaslc.org/wp-content/uploads/2019/08/WCLC2019-Abstract-Book_web-friendly.pdf#page=328 Authors:Kerrigan, KC, Halland, B, Adamson, BJS, Patel, SB, Akerley, WL Sources:World Conference on Lung Cancer Share Posted inPublicationsUnmet needNon-small cell lung cancer More publicationsWorld Conference on Lung CancerAugust 2025Disease burden and rwPFS as a surrogate endpoint for rwOS in NTRK+ NSCLC and other advanced/metastatic solid tumorFlores Avile C, Su I-H, Huang P-C, Cho-Phan C, Camidge R, Yuan Y.Publication summaryPublicationsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Evolving treatment patterns in early-stage non-small cell lung cancer in the USGray J E, Thoele K, Gilligan A M, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Real-world biomarker testing and treatment initiation in patients with resected early-stage NSCLC (eNSCLC) in the US and UKRinaldi C, Halloran S, Pittel H, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancer